Home
Scientific Advisory Board
Grants
Dermigen Publications
Contact Us

Page Two Text

Dermigen's Scientific Advisory Board


  • Thomas J. Slaga, Ph.D.

    President and CEO
    AMC Cancer Research Center
    Denver, Colorado

Expertise: 
Ce
llular and molecular mechanisms of multistage carcinogenesis.


  • John DiGiovanni, Ph.D.

    Director
    Science Park – Research Division
    University of Texas M.D. Anderson Cancer Center
    Smithville, Texas

Expertise: 
Cellular and molecular mechanisms of multistage carcinogenesis.


  • Claudio J. Conti, D.V.M., Ph.D.

    Science Park - Research Division
    University of Texas M.D. Anderson Cancer Center
    Smithville, Texas
             

          Expertise: 
          Cellular and molecular mechanisms of multistage carcinogenesis.


  • James E. Klaunig, Ph.D.

          Director, Division of Toxicology
          Department of Pharmacology and Toxicology
          Indiana University School of Medicine
          Indianapolis, Indiana

          Expertise: 
          Cellular and molecular mechanisms of chemically induced toxicity, particularly in the liver.


  • Donald E. Stevenson, Ph.D., MRCVS, FRCPath

    Dermigen Consulting Group   
    Smithville, Texas

Expertise: 
Cellular and molecular mechanisms of chemically induced liver toxicity, particularly the hepatotoxicity of pesticides; cancer risk assessment.

 
Content updated and ©2006 by Dermigen